Cite Filings / ABUS / 0000895421-26-000284
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SCHEDULE 13G/A

Statement of Beneficial Ownership

Arbutus Biopharma Corp · Filed 2026-10-07 · Acc 0000895421-26-000284

Documents 1

  • SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

  • 2026-10-27 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-10-07 4 Director returned 17,948 shares (to the company)
  • 2026-10-07 4 Chief Financial Officer returned 48,081 shares (to the company)
  • 2026-10-07 4 Director returned 17,142 shares (to the company)
  • 2026-10-07 4 President and CEO returned 24,655 shares (to the company)
  • 2026-10-07 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-08-12 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · Two Seas Capital LP 4.1%
  2. 2026-11-16 SCHEDULE 13G/A · Whitefort Capital Master Fund, LP 1.6%
  3. 2026-11-16 SCHEDULE 13G · NOMURA HOLDINGS INC 7.3%
  4. 2026-10-05 SCHEDULE 13D/A · Roivant Sciences Ltd. 19.5%
Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…